Stuart A. Arbuckle
2015
In 2015, Stuart A. Arbuckle earned a total compensation of $8.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $721,500 |
|---|---|
| Option Awards | $5,199,586 |
| Salary | $629,262 |
| Stock Awards | $2,258,991 |
| Other | $13,110 |
| Total | $8,822,449 |
Arbuckle received $5.2M in option awards, accounting for 59% of the total pay in 2015.
Arbuckle also received $721.5K in non-equity incentive plan, $629.3K in salary, $2.3M in stock awards and $13.1K in other compensation.
Rankings
In 2015, Stuart A. Arbuckle's compensation ranked 654th out of 13,638 executives tracked by ExecPay. In other words, Arbuckle earned more than 95.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 654 out of 13,638 | 95th |
Division Manufacturing | 227 out of 5,187 | 96th |
Major group Chemicals And Allied Products | 83 out of 1,857 | 96th |
Industry group Drugs | 63 out of 1,531 | 96th |
Industry Pharmaceutical Preparations | 50 out of 1,179 | 96th |
Source: SEC filing on April 28, 2017.
Arbuckle's colleagues
We found four more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2015.